The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple COVID-19 variants.

What is HBV reactivation? Read on to learn more about this potential complication, including possible causes, symptoms, and treatment options.

Test results for hepatitis B can seem confusing, but they don't have to be. Let's review what the presence or absence or these antibodies means for you: ...

A hepatitis B nonreactive test result can mean a person is not immune to the virus. Learn how the test works, how to interpret the results, and the next steps.

The effectiveness of the engineered investigational human monoclonal antibody VIR-3434 in inhibiting viral spread in hepatitis B and D viruses demonstrated.

To explore the connection between the new BCR repertoire data generated here and known SARS-CoV2 antibody sequences we took a two way approach. Building on the hypothesis that the whole repertoire ...

And because the model was trained on species other than humans, it can be used to generate antibodies for mice, primates, and others, in addition to humans. SARS CoV2 (the virus that causes COVID-19), ...

A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models.

A new imaging approach monitors antibody responses to vaccines more quickly than current techniques, which could accelerate vaccine design ...

A three-antigen hepatitis B vaccine (3A-HBV) induced higher hepatitis B surface antibody (anti-HB) concentrations and seroprotection versus the single-antigen vaccine (1A-HBV) in a phase III trial.

What is monoclonal antibody therapy? When a patient undergoes monoclonal antibody therapy, they are infused with high concentrations of antibodies engineered to fight the coronavirus.